According to Hanjo Kim, senior vice president (SVP) of Global Strategy and Head of Medicinal Chemistry at Standigm, the next research trends in AI will be toward obesity and longevity: “Many people believe obesity is the only remaining disease to conquer among metabolic diseases.
According to Hanjo Kim, senior vice president (SVP) of Global Strategy and Head of Medicinal Chemistry at Standigm, the next research trends in AI will be toward obesity and longevity: “Many people believe obesity is the only remaining disease to conquer among metabolic diseases. As it is very complicated and mingled with other metabolic diseases, GLP-1 drugs will replace Lipitors. Furthermore, scientific findings about mitochondria are exciting as they show it is related to many diseases and complications. Aging relates to the energy expenditure of the human body and mitochondria could be a rich field for study since they are the energy factory of most cells.”